Association of different types of liver disease with demographic and clinical factors

BioMedicine (Netherlands)

Volumn 6, Issue 3, 2016, Pages 16-22

  Cheng, Kao Chi ^a,b   Lin, Wen Yuan ^a,b   Liu, Chiu Shong ^a,b   Lin, Cheng Chieh ^a,b   Lai, Hsueh Chou ^b,c   Lai, Shih Wei ^a,b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cirrhosis; Fatty liver; Globulin albumin ratio; Hemangioma; Hepatitis; Liver cyst

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLOBULIN;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GALLSTONE; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 84981717472     PISSN: 22118020     EISSN: 22118039     Source Type: Journal    
DOI: 10.7603/s40681-016-0016-2     Document Type: Article

References (16)

1. th Edition. Philadelphia: WB Saunders Co; 2006.
2. Grant A, Neuberger J. Guidelines on the use of liver biopsy in clinical practice. Gut 1999; 45: 1-11
3. Williams AL, Hoofnagle JH. Ratio of serum aspartate to alanine aminotransferase in chronic hepatits. Relationship to cirrhosis. Gastroenterology 1988; 95: 734-9
4. Sheth SG, Flamm SL, Gordon FD, Chopra S. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am. J Gastroenterol 1998; 93: 44-8
5. Luo JC, Hwang SJ, Chang FY, Chu CW, Lai CR, Wang YJ, et al. Simple blood tests can predict compensated liver cirrhosis in patients with chronic hepatitis C. Hepatogastroenterology 2002; 49: 478-81
6. Luscombe C, Pedersen J, Bowden S, Locarini S. Alterations in intrahepatic expression of duck hepatitis B viral markers with ganciclovir chemotherapy. Liver 1994; 14: 182-92
7. Krier M, Ahmed A. The asymptomatic outpatient with abnormal liver function tests. Clin Liver Dis 2009; 13: 167-77
8. Sporea I, Popescu A, Sirli R. Why, who and how should perform liver biopsy in chronic liver diseases. World J Gastroenterol 2008; 14: 3396-402
9. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-57
10. Czaja AJ, Wolf AM, Baggenstoss AH. Clinical assessment of cirrhosis in severe chronic active liver disease. Specificity and sensitivity of physical and laboratory findings. Mayo Clin Proc 1980; 55: 360-4
11. Stobo JD. Cirrhosis and hypergammaglobulinemia. Dig Dis Sci 1979; 24: 737-40
12. Aster RH. Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. J Clin Invest 1966; 45: 645-57
13. Martin TG 3rd, Somberg KA, Meng YG, Cohen RL, Heid CA, de Sauvage FJ, et al. Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation. Ann Intern Med 1997; 127: 285-8
14. Peck-Radosavljevic M, Zacherl J, Meng YG, Pidlich J, Lipinski E, Längle F, et al. Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver. J Hepatol 1997; 27: 127-31
15. Callewaert N, Van Vlierberghe H, Van Hecke A, Laroy W, Delanghe J, Contreras R. Noninvasive diagnosis of liver cirrhosis using DNA sequenced-based total serum protein glycomics. Nat Med 2004; 10: 1-6
16. Halfon P, Munteanu M, Poynard T. FibroTest-ActiTest as a noninvasive marker of liver fibrosis. Gastroenterol Clin Biol 2008; 32: 22-39